| pubmed-article:1672597 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C0069515 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C0746922 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C1446409 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C1704824 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C0812425 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C2700445 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C2697524 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C1706163 | lld:lifeskim |
| pubmed-article:1672597 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:1672597 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1672597 | pubmed:dateCreated | 1991-5-3 | lld:pubmed |
| pubmed-article:1672597 | pubmed:abstractText | An immunohistochemical study was performed on 211 primary breast carcinomas for c-erbB-2 expression. All patients had involvement of axillary lymph nodes and all were randomised onto one of the Ludwig Breast Cancer Trials I-IV between July 1978 and August 1981. c-erbB-2 overexpression significantly correlated with high S-phase fraction, four or more positive axillary nodes involved, estrogen receptor negative primaries, progesterone receptor negative primaries, high grade tumours and DNA aneuploidy. With a nine year median follow-up c-erbB-2 positive tumours had worse disease-free survival (p = 0.0002) and overall survival (p less than 0.0001). Multivariate analyses using proportional hazard regression models demonstrated that c-erbB-2 positivity continued to predict a poor outcome even when accounting for the effects of other prognostic factors. | lld:pubmed |
| pubmed-article:1672597 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1672597 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1672597 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1672597 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1672597 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1672597 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1672597 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1672597 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1672597 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:1672597 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:1672597 | pubmed:author | pubmed-author:GustersonB... | lld:pubmed |
| pubmed-article:1672597 | pubmed:author | pubmed-author:GelberR DRD | lld:pubmed |
| pubmed-article:1672597 | pubmed:author | pubmed-author:GoldhirschAA | lld:pubmed |
| pubmed-article:1672597 | pubmed:author | pubmed-author:AnbazhaganRR | lld:pubmed |
| pubmed-article:1672597 | pubmed:author | pubmed-author:BettelheimRR | lld:pubmed |
| pubmed-article:1672597 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1672597 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:1672597 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1672597 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1672597 | pubmed:pagination | 47-53 | lld:pubmed |
| pubmed-article:1672597 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:meshHeading | pubmed-meshheading:1672597-... | lld:pubmed |
| pubmed-article:1672597 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1672597 | pubmed:articleTitle | Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer. | lld:pubmed |
| pubmed-article:1672597 | pubmed:affiliation | International Breast Cancer Study Group, Haddow Laboratories, Sutton, Surrey, UK. | lld:pubmed |
| pubmed-article:1672597 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1672597 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1672597 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1672597 | lld:pubmed |
